Advertisement

Pharmaceutical Chemistry Journal

, Volume 30, Issue 4, pp 241–244 | Cite as

A comparative study of chromone and 4-oxopyrimidine derivatives possessing antiallergic activity by methods of molecular mechanics and molecular orbitals

  • E. T. Oganesyan
  • A. V. Pogrebnyak
  • L. S. Sarkisov
  • A. V. Ivchenko
  • I. P. Kodonidi
  • A. S. Saraf
  • A. A. Prokopov
Search for New Drugs
  • 14 Downloads

Keywords

Organic Chemistry Molecular Mechanic Molecular Orbital Chromone Antiallergic Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    É. T. Oganesyan, A. V. Ivchenko, I. P. Kodonidi, et al.,Khim. Farm. Zh.,27(3), 10 - 12 (1993).Google Scholar
  2. 2.
    É. T. Oganesyan, A. S. Saraf, and A. V. Ivchenko,Khim.-Farm. Zh.,27(1), 41 - 43 (1993).Google Scholar
  3. 3.
    É. T. Oganesyan, L. S. Sarkisov, and A. V. Ivchenko,Khim. Farm. Zh.,30(2), 33 - 35 (1995).Google Scholar
  4. 4.
    S. Fernandes-Gallardo, M. Gijon, C. Garcia, et al.,Br. J. Pharmacol.,105, 119 - 125 (1992).Google Scholar
  5. 5.
    V. B. Weg, M. L. Watson, and R. S. B. Cordeiro,Eur. J. Pharmacol,204, 157 - 163 (1991).Google Scholar
  6. 6.
    N. L. Allinger and J. T. Sprague,J. Am. Chem. Soc.,95, 3893 - 3896 (1973).Google Scholar
  7. 7.
    M. J. S. Dewar and W. Thiel,J. Am. Chem. Soc.,99, 4899 - 4903 (1977).Google Scholar
  8. 8.
    L. A. Griffiths,Biochem. J.,92, 173 - 179 (1964).Google Scholar
  9. 9.
    J. Kao and N. L. Allinger,J. Am. Chem. Soc.,99, 975 - 978 (1977).Google Scholar
  10. 10.
    H. Perrin and G. Berges,Theochem,1, 299 (1981).Google Scholar
  11. 11.
    A. I. Kitaigorodskii, P. M. Zorkii, and V. K. Bel'skii,Structure of Organic Matter [in Russian], Moscow (1982).Google Scholar
  12. 12.
    H. J. Chiang and S. D. Worley,J. Electron Spectrosc. Relat. Phenom.,21, 121 - 123 (1980).Google Scholar
  13. 13.
    B. W. Clare,J. Med. Chem.,33, 687 - 702 (1990).Google Scholar
  14. 14.
    V. V. Ezhov and A. V. Titov,Khim.-Farm. Zh.,17(6), 761 - 763 (1983).Google Scholar
  15. 15.
    É. T. Oganesyan, A. V. Pngrehnyak, and Yu. S. Gridnev,Khim. Farm. Zh.,23(11), 36 - 39 (1994).Google Scholar
  16. 16.
    S. Miyamoto and M. Yoshimoto,Chem. Pharm. Bull. Jpn.,35(11), 4510 - 4516 (1987).Google Scholar
  17. 17.
    P. G. Gardiner, T. S. Abram, and N. J. Cuthbert,Eur. J. Pharmacol.,182, 291 - 299 (1990).Google Scholar
  18. 18.
    J. Kao and N. L. Allinger,Quantum Chemistry Program Exchange (QCPE), No. 395 + 318(Pl), Indiana University. Bloomington, Indiana, USA (1988).Google Scholar
  19. 19.
    W. Thiel,Quantum Chemistry Program Exchange (QCPE), No. 353, Indiana University, Bloomington, Indiana, USA (1975).Google Scholar

Copyright information

© Plenum Publishing Corporation 1997

Authors and Affiliations

  • E. T. Oganesyan
    • 1
  • A. V. Pogrebnyak
    • 1
  • L. S. Sarkisov
    • 1
  • A. V. Ivchenko
    • 1
  • I. P. Kodonidi
    • 1
  • A. S. Saraf
    • 1
  • A. A. Prokopov
    • 1
  1. 1.Pyatigorsk Pharmaceutical InstitutePyatigorskRussia

Personalised recommendations